Oncotelic Therapeutics, Inc. (OTLC) Operating margin 2021–2024
Oncotelic Therapeutics, Inc. (OTLC) operating margin by fiscal year — reported operating income divided by reported revenue.
-5108.6%FY2024 · since FY2021: -524.2% → -5108.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -5108.6% | — |
| FY2021 | -524.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OTLC financial trends
OTLC RevenueOTLC Net incomeOTLC Net marginOTLC Gross profitOTLC Gross marginOTLC Operating incomeOTLC Operating cash flowOTLC Free cash flowOTLC Capital expendituresOTLC Return on equityOTLC Stock buybacksOTLC Dividends paidOTLC Total assetsOTLC Total liabilitiesOTLC Shareholders’ equityOTLC overview →